Sinphar Pharmaceutical (1734.TW) Earnings Analysis
Sinphar Pharmaceutical (1734.TW) next reports earnings on 2026-08-07. Last quarter (2026-03-10) it beat with EPS 0.54 TWD vs 0.4286 TWD est (+26%). It has beaten estimates in 2/3 recent quarters (67%). Trailing P/E 18.60.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does 1734.TW next report earnings?
| Next earnings date | 2026-08-07 |
|---|---|
| Consensus EPS estimate | n/a |
| Revenue estimate | n/a |
1734.TW earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-03-10 | 0.54 TWD | 0.4286 TWD | +26% | Beat |
| 2025-05-09 | 0.62 TWD | 0.43 TWD | +44.2% | Beat |
| 2025-03-20 | 0.45 TWD | 0.5 TWD | -10% | Miss |
| 2024-09-30 | 0.26 TWD | n/a | n/a | n/a |
Beat rate: 2/3 (67%) over reported quarters with consensus data.
1734.TW valuation and analyst view
| Trailing P/E | 18.60 |
|---|---|
| Trailing EPS | 1.87 TWD |
| Price / book | 1.61 |
| Dividend yield | 2.93% |
| Market cap | 6.25B |
Limited or no published sell-side analyst coverage for this symbol.
Related research pages
Frequently asked questions
When is Sinphar Pharmaceutical (1734.TW)'s next earnings date?
Sinphar Pharmaceutical is next scheduled to report on 2026-08-07.
Did 1734.TW beat earnings last quarter?
In its 2026-03-10 report, 1734.TW posted EPS of 0.54 TWD versus a 0.4286 TWD estimate — a beat of 26%.
What is 1734.TW's earnings track record?
Over the last 3 reported quarters with consensus data, 1734.TW beat estimates 2 times (67%).
What is 1734.TW's current P/E ratio and EPS?
1734.TW trades at a trailing P/E of 18.60 on trailing EPS of 1.8696439796559803 TWD.
What do analysts rate 1734.TW?
1734.TW has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.